Skip to content

To compare efficacy of Laryngeal nerve block with, without laryngeal nerve block on throat soarness after Double lumen endotracheal intubation

Comparison of Preoperative ultrasound -guided Internal Branch Block of Superior Laryngeal Nerve with placebo on Postoperative Sore Throat caused by Double Lumen Endotracheal Intubation: A Randomized placebo control Trial - NIL

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/078982
Enrollment
152
Registered
2025-01-20
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J958- Other intraoperative and postprocedural complications and disorders of respiratory system, not elsewhere classified

Interventions

Intervention1: Use of double lumen endobronchial tube (DLT) with superior laryngeal nerve block: Group T- will receive USG guided Internal superior laryngeal nerve block (iSLN) with 2mL(0.2%) ropiva

Sponsors

Dr Rishikesh
Lead Sponsor
Dr Alok Kumar Bharti
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: All patients having age between 18-65 years with either sex, posted for thoracotomy requiring DLT insertion and duration of surgery of 2-3 hours will be performed USG guided internal superior laryngeal nerve block with 2 ml ( 0.2 %) ropivacaine after DLT insertion

Exclusion criteria

Exclusion criteria: patient will be excluded fro study are surgery performed in the neck, mouth, or throat area, recent or ongoing upper respiratory infection, and existing preoperative sore throat cases.

Design outcomes

Primary

MeasureTime frame
To measure incidence of sore throat within 24hrs of surgeryTimepoint: To measure incidence of sore throat within 24hrs of surgery

Secondary

MeasureTime frame
a)To assess severity of sore throat assessed at study time points (0.5, 2, 6 and 24 h) b)To assess hemodynamic at regular time points c)To assess any complication related to block Timepoint: At 0.5 , 2 , 6 and 24 hours

Countries

India

Contacts

Public ContactDr Rishikesh

Indira Gandhi Institute of Medical Sciences, Patna

deepakswat@yahoo.com9113463130

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026